Nautilus Biotechnology, Inc. (NAUT)
NASDAQ: NAUT · Real-Time Price · USD
2.380
+0.040 (1.71%)
At close: Nov 21, 2024, 4:00 PM
2.310
-0.070 (-2.94%)
After-hours: Nov 21, 2024, 5:23 PM EST
Nautilus Biotechnology Analyst Ratings
Total Analysts
2
Consensus Rating
Buy
Price Target
$4.50
Upside
+89.08%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +152.10% | Jun 27, 2024 |
| Jefferies | Jefferies | Strong Buy → Hold Initiates $5 → $3 | Strong Buy → Hold | Initiates | $5 → $3 | +26.05% | Jun 3, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Reiterates $6 | Hold | Reiterates | $6 | +152.10% | Aug 3, 2023 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $8 → $6 | Hold | Maintains | $8 → $6 | +152.10% | Aug 3, 2022 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $4 → $2 | Hold | Maintains | $4 → $2 | -15.97% | Aug 3, 2022 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $5 → $4 | Hold | Maintains | $5 → $4 | +68.07% | Jul 14, 2022 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $9 → $5 | Hold | Maintains | $9 → $5 | +110.08% | Apr 13, 2022 |
| Morgan Stanley | Morgan Stanley | Hold Initiates $8 | Hold | Initiates | $8 | +236.13% | Jan 6, 2022 |
| Cowen & Co. | Cowen & Co. | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Nov 2, 2021 |
| Goldman Sachs | Goldman Sachs | Hold Initiates $10 | Hold | Initiates | $10 | +320.17% | Aug 4, 2021 |
| Jefferies | Jefferies | Strong Buy Initiates $13 | Strong Buy | Initiates | $13 | +446.22% | Jul 13, 2021 |